Results 161 to 170 of about 39,412 (236)

Agonist antibody to guanylate cyclase receptor NPR1 regulates vascular tone. [PDF]

open access: yesNature
Dunn ME   +43 more
europepmc   +1 more source

A Phase II study of avenciguat, a novel soluble guanylate cyclase activator, in patients with systemic sclerosis: Study design and rationale of the VITALISScE™ study. [PDF]

open access: yesJ Scleroderma Relat Disord
Khanna D   +9 more
europepmc   +1 more source

A novel soluble guanylate cyclase activator, avenciguat, in combination with empagliflozin, protects against renal and hepatic injury in diabetic db/db mice. [PDF]

open access: yesAm J Physiol Endocrinol Metab
Sharma N   +8 more
europepmc   +1 more source

MK-5475, an inhaled soluble guanylate cyclase stimulator, for treatment of pulmonary arterial hypertension: the INSIGNIA-PAH study. [PDF]

open access: yesEur Respir J
Humbert M   +8 more
europepmc   +1 more source

Expression of guanylate cyclase C in human prefrontal cortex depends on sex and feeding status. [PDF]

open access: yesFront Mol Neurosci
Ratko M   +7 more
europepmc   +1 more source

Expression of soluble guanylate cyclase (sGC) and its ability to form a functional heterodimer are crucial for reviving the NO-sGC signaling in PAH. [PDF]

open access: yesFree Radic Biol Med
Sumi MP   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy